Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial
Schulberg, Julien D, Wright, Emily K, Holt, Bronte A, Hamilton, Amy L, Sutherland, Tom R, Ross, Alyson L, Vogrin, Sara, Miller, Ashley M, Connell, William C, Lust, Mark, Ding, Nik S, Moore, Gregory T, Bell, Sally J, Shelton, Edward, Christensen, Britt, De Cruz, Peter, Rong, Yuwei J, Kamm, Michael A
Published in The lancet. Gastroenterology & hepatology (01.04.2022)
Published in The lancet. Gastroenterology & hepatology (01.04.2022)
Get more information
Journal Article
459 CROHN'S DISEASE STRICTURES RESPOND TO DRUG TREATMENT AND TREAT-TO-TARGET INTENSE COMBINATION THERAPY IS MORE EFFECTIVE THAN STANDARD ANTI-TNF THERAPY. THE STRIDENT RANDOMISED CONTROLLED TRIAL
Schulberg, Julien D., Wright, Emily K., Holt, Bronte A., Sutherland, Tom, Ross, Alyson, Hamilton, Amy L., Vogrin, Sara, Miller, Ashley M., Connell, William, Lust, Mark, Ding, Nik S., Moore, Gregory T., Bell, Sally J., Shelton, Edward, Christensen, Britt, De Cruz, Peter, Rong, Yuwei J., Kamm, Michael A.
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2021)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2021)
Get full text
Journal Article